Investigation of the Efficacy of Telerehabilitation in Patients With Rotator Cuff Tendinopathy

Sponsor
Izmir Democracy University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06024551
Collaborator
(none)
30
1
2
4.9
6.2

Study Details

Study Description

Brief Summary

The goal of this study is to investigate the effect of telerehabilitation in patients with rotator cuff tendinopathy. The main questions it aims to answer are:

  • Is telerehabilitation effective in improving the functional status of patients with rotator cuff tendinopathy?

  • Is telerehabilitation effective in reducing the pain of rotator cuff patients?

Condition or Disease Intervention/Treatment Phase
  • Other: Telerehabilitation
  • Other: home exercise program
N/A

Detailed Description

Patients between the ages of 18-65 who were diagnosed with rotator cuff tendinopathy will be included in the study. Patients will be divided into two groups. Patients in group 1 will be given a home exercise program. Then, the patients will be called 3 times a week and it will be evaluated whether they do their exercises regularly and whether they do it correctly. At the end of the first month, the patients will be evaluated again for functionality and pain.

The patients in group 2 will be given a home exercise program and at the end of the first month, the patients will be evaluated again in terms of functionality and pain.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Investigation of the Efficacy of Telerehabilitation in Patients With Rotator Cuff Tendinopathy
Actual Study Start Date :
Aug 4, 2023
Anticipated Primary Completion Date :
Dec 4, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

Patients who receive telerehabilitation

Other: Telerehabilitation
Patients in this arm will be given telerehabilitation three times a week, for four weeks.

Other: Control Group

Patients who receive home exercise program

Other: home exercise program
Patients in this arm will receive home exercise program for four weeks

Outcome Measures

Primary Outcome Measures

  1. Western Ontario Rotator Cuff Index [one month]

    Western Ontario Rotator Cuff Index is a disease-specific quality of life questionnaire, evaluating the change in symptoms and functional ability, specific to a Rotator Cuff tendinopathy. Raw scores range from 0 to 2100 with a higher score indicating decreased quality of life.

  2. Simple Shoulder Test [one month]

    A questionnaire about the function of the involved shoulder. Overall scored is calculated by number of yes/number of completed items. Minimum score is 0 %and maximum is 100 %. Higher scores indicate better function.

Secondary Outcome Measures

  1. Range of motion [one month]

    shoulder range of motion will be measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of Rotator cuff tendinopathy

  • Being able to do the prescribed exercises

  • Having an access to internet and having a computer or smart phone for telerehabilitation

Exclusion Criteria:
  • Patients with a neurological disease that may affect the effectiveness of exercise

  • History of fracture in shoulder region

  • History of surgery in shoulder region

  • Patients with a psychiatric disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Izmir Democracy University İzmir Turkey

Sponsors and Collaborators

  • Izmir Democracy University

Investigators

  • Study Director: Ferruh Taşpınar, Izmir Democracy University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ferruh Taşpınar, Associate Professor, Izmir Democracy University
ClinicalTrials.gov Identifier:
NCT06024551
Other Study ID Numbers:
  • TR35TR
First Posted:
Sep 6, 2023
Last Update Posted:
Sep 6, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ferruh Taşpınar, Associate Professor, Izmir Democracy University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 6, 2023